Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. 詳細を表示
Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne PR Newswire WEST SACRAMENTO, Calif., Nov. 25, 2024 WEST SACRAMENTO, Calif., Nov...
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES PR Newswire MINNEAPOLIS, Nov. 20, 2024 MINNEAPOLIS, Nov. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO PR Newswire MINNEAPOLIS, Nov. 14, 2024 Customers will present data from their use of...
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS PR Newswire MINNEAPOLIS, Nov. 11, 2024 R&D Systems Hematology Controls and Calibrators has completed the Class...
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS PR Newswire MINNEAPOLIS, Nov. 11, 2024 R&D Systems Hematology Controls and Calibrators has completed the Class C...
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES PR Newswire MINNEAPOLIS, Nov. 8, 2024 MINNEAPOLIS, Nov. 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will...
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy PR Newswire ST. PAUL, Minn., Nov. 7...
BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING PR Newswire MINNEAPOLIS, Nov. 6, 2024 MINNEAPOLIS, Nov. 6, 2024 /PRNewswire/ -- Bio-Techne Corporation...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 8.145 | 12.2068190333 | 66.725 | 75 | 65.61 | 1228852 | 69.95893849 | CS |
4 | 4.74 | 6.75887637245 | 70.13 | 79.86 | 65.61 | 1213946 | 72.24730862 | CS |
12 | 1.165 | 1.58062546639 | 73.705 | 80.9499 | 65.61 | 936001 | 73.27873792 | CS |
26 | -5.93 | -7.33910891089 | 80.8 | 83.62 | 65.61 | 961169 | 74.30159183 | CS |
52 | 11.12 | 17.4431372549 | 63.75 | 85.57 | 61.16 | 1032212 | 72.87580557 | CS |
156 | -44.24 | -37.1421375199 | 119.11 | 130.74 | 51.79 | 758261 | 76.3593384 | CS |
260 | 19.77 | 35.8802177858 | 55.1 | 135.9625 | 38.7925 | 538693 | 78.00604509 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約